02/20/2020
3:28 PM | Eyepoint Pharmaceuticals (Filer)
| Form 424B5
| |
02/04/2020
5:02 AM | Eyepoint Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/23/2020
12:11 PM | Eyepoint Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/16/2020
10:58 AM | Eyepoint Pharmaceuticals (Filer)
| Form 8-K/A
| |
11/27/2019
4:22 PM | Eyepoint Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/22/2019
10:41 AM | Eyepoint Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/19/2019
8:54 AM | Eyepoint Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2019
7:42 AM | Elston George (Reporting)
Eyepoint Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/18/2019
7:41 AM | Elston George (Reporting)
Eyepoint Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/07/2019
3:37 PM | Eyepoint Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2019
6:00 AM | Eyepoint Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2019
5:04 PM | Eyepoint Pharmaceuticals (Issuer)
Lurker Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2019
5:03 PM | Eyepoint Pharmaceuticals (Issuer)
Paggiarino Dario A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/11/2019
5:13 PM | Eyepoint Pharmaceuticals (Issuer)
Mazzo David J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2019
7:46 AM | Eyepoint Pharmaceuticals (Issuer)
Mazzo David J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2019
3:05 PM | Eyepoint Pharmaceuticals (Filer)
| Form 8-K/A
| |
08/22/2019
4:25 PM | Eyepoint Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2019
3:38 PM | Eyepoint Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/07/2019
2:37 PM | Eyepoint Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/07/2019
6:00 AM | Eyepoint Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2019
3:02 PM | Eyepoint Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/16/2019
3:39 PM | DICICCO WENDY F (Reporting)
Eyepoint Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2019
3:37 PM | DICICCO WENDY F (Reporting)
Eyepoint Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/11/2019
3:02 PM | Eyepoint Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2019
4:04 PM | Eyepoint Pharmaceuticals (Issuer)
Ross Leonard S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2019
4:04 PM | Eyepoint Pharmaceuticals (Issuer)
Paggiarino Dario A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2019
4:03 PM | Eyepoint Pharmaceuticals (Issuer)
Lurker Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2019
3:53 PM | Eyepoint Pharmaceuticals (Issuer)
ROGERS MICHAEL W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2019
3:52 PM | Eyepoint Pharmaceuticals (Issuer)
Mazzo David J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2019
3:52 PM | Duker Jay S. (Reporting)
Eyepoint Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2019
3:51 PM | Eyepoint Pharmaceuticals (Issuer)
Landis John B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2019
3:51 PM | Eyepoint Pharmaceuticals (Issuer)
Godshall Douglas Evan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2019
3:51 PM | Eyepoint Pharmaceuticals (Issuer)
Peterson Kristine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2019
3:50 PM | ANDO GORAN (Reporting)
Eyepoint Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2019
3:50 PM | Eyepoint Pharmaceuticals (Issuer)
Lurker Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2019
3:49 PM | Eyepoint Pharmaceuticals (Issuer)
Price David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2019
3:48 PM | Eyepoint Pharmaceuticals (Issuer)
Paggiarino Dario A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2019
3:31 PM | Eyepoint Pharmaceuticals (Issuer)
ROGERS MICHAEL W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2019
3:29 PM | Eyepoint Pharmaceuticals (Issuer)
Peterson Kristine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2019
3:29 PM | Eyepoint Pharmaceuticals (Issuer)
Godshall Douglas Evan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2019
3:28 PM | Duker Jay S. (Reporting)
Eyepoint Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2019
4:42 PM | Eyepoint Pharmaceuticals (Issuer)
Lurker Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2019
4:41 PM | Eyepoint Pharmaceuticals (Issuer)
Ross Leonard S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2019
4:40 PM | Eyepoint Pharmaceuticals (Issuer)
Paggiarino Dario A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2019
3:38 PM | Eyepoint Pharmaceuticals (Issuer)
Jones David Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2019
3:34 PM | Eyepoint Pharmaceuticals (Issuer)
Jones David Scott (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/22/2019
8:00 AM | Eyepoint Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2019
6:01 AM | Eyepoint Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2019
4:30 PM | Eyepoint Pharmaceuticals (Filer)
| Form DEFA14A
| |
04/29/2019
4:29 PM | Eyepoint Pharmaceuticals (Filer)
| Form DEF 14A
| |
04/26/2019
7:49 AM | Eyepoint Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2019
7:16 AM | Duker Jay S. (Reporting)
Eyepoint Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2019
7:25 AM | Duker Jay S. (Reporting)
Eyepoint Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2019
7:24 AM | Eyepoint Pharmaceuticals (Issuer)
Ross Leonard S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2019
4:01 PM | Eyepoint Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2019
7:23 AM | Eyepoint Pharmaceuticals (Issuer)
Lurker Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2019
7:21 AM | Eyepoint Pharmaceuticals (Issuer)
Mazzo David J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2019
7:20 AM | Eyepoint Pharmaceuticals (Issuer)
Godshall Douglas Evan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2019
4:29 PM | Eyepoint Pharmaceuticals (Filer)
| Form 424B5
| |
03/27/2019
3:27 PM | Eyepoint Pharmaceuticals (Filer)
| Form 424B5
| |
03/21/2019
4:24 PM | Eyepoint Pharmaceuticals (Issuer)
Paggiarino Dario A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2019
4:22 PM | Eyepoint Pharmaceuticals (Issuer)
Ross Leonard S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2019
4:30 PM | Eyepoint Pharmaceuticals (Filer)
| Form 10-KT
| |
03/14/2019
6:00 AM | Eyepoint Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/19/2019
3:00 PM | Eyepoint Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2019
1:36 PM | EW Healthcare Partners, L.P. (Filed by)
Eyepoint Pharmaceuticals (Subject)
| Form SC 13D/A
| |
02/13/2019
1:31 PM | Essex Woodlands Fund IX-GP, L.P. (Reporting)
Essex Woodlands IX, LLC (Reporting)
EW Healthcare Partners, L.P. (Reporting)
EW Healthcare Partners-A, L.P. (Reporting)
Eyepoint Pharmaceuticals (Issuer)
| Form 5
Annual statement of changes in beneficial ownership of securities | |
01/29/2019
3:08 PM | Eyepoint Pharmaceuticals (Issuer)
GUYER DAVID R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2019
3:02 PM | Eyepoint Pharmaceuticals (Issuer)
GUYER DAVID R (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/29/2019
3:02 PM | Eyepoint Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/18/2019
3:59 PM | Eyepoint Pharmaceuticals (Filer)
| Form 424B5
| |
01/18/2019
3:50 PM | Eyepoint Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/14/2019
7:29 AM | Eyepoint Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/04/2019
3:06 PM | Eyepoint Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/26/2018
3:06 PM | Eyepoint Pharmaceuticals (Issuer)
Ross Leonard S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2018
11:15 PM | Eyepoint Pharmaceuticals (Filer)
| Form EFFECT
| |
11/28/2018
4:18 PM | Eyepoint Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/16/2018
3:00 PM | Eyepoint Pharmaceuticals (Issuer)
ROGERS MICHAEL W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/09/2018
3:23 PM | Eyepoint Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2018
6:20 AM | Eyepoint Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2018
11:15 PM | Eyepoint Pharmaceuticals (Filer)
| Form EFFECT
| |
10/31/2018
4:29 PM | Eyepoint Pharmaceuticals (Filer)
| Form S-3/A
| |
10/29/2018
3:36 PM | Eyepoint Pharmaceuticals (Filer)
| Form 10-K/A
| |
10/29/2018
3:03 PM | Eyepoint Pharmaceuticals (Issuer)
Landis John B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/29/2018
3:00 PM | Eyepoint Pharmaceuticals (Issuer)
Landis John B. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/16/2018
3:00 PM | Eyepoint Pharmaceuticals (Issuer)
Lurker Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2018
3:00 PM | Eyepoint Pharmaceuticals (Issuer)
Ross Leonard S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2018
3:00 PM | Eyepoint Pharmaceuticals (Issuer)
Paggiarino Dario A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2018
4:13 PM | Eyepoint Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2018
3:05 PM | ANDO GORAN (Reporting)
Eyepoint Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/28/2018
3:02 PM | Eyepoint Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2018
4:31 PM | Eyepoint Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
09/18/2018
3:15 PM | Eyepoint Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
09/12/2018
4:27 PM | Eyepoint Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2018
6:06 PM | Eyepoint Pharmaceuticals (Issuer)
Mazzo David J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/17/2018
8:02 AM | Eyepoint Pharmaceuticals (Filer)
| Form S-3/A
| |
08/03/2018
3:06 PM | Eyepoint Pharmaceuticals (Issuer)
Price David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/03/2018
3:05 PM | Eyepoint Pharmaceuticals (Issuer)
Price David (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/03/2018
3:01 PM | Eyepoint Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/25/2018
4:27 PM | Eyepoint Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
